The 10/90 gap in sub-Saharan Africa: Resolving inequities in health research

2009 2000 Adams, 2006, Estimating the cost of new drug development: is it really 802 million dollars?, Health Affairs, 25, 420, 10.1377/hlthaff.25.2.420 Bloom, 2006, Priorities for global research and development of interventions 2004 2008 1990 Council for International Organizations of Medical Sciences (CIOMS), 2002 DiMasi, 2003, The price of innovation: new estimates of drug development costs, Health Econ., 22, 151, 10.1016/S0167-6296(02)00126-1 Doyal, 2008, Gender and the 10/90 gap in health research, Bull. World Health Organizat., March, 162 Frost, 2008 Gallup, 2001, The economic burden of malaria, Am. J. Trop. Med. Hygiene, 64, 85, 10.4269/ajtmh.2001.64.85 Hotez, 2007, Control of neglected tropical diseases, N. Eng. J. Med., 357, 1018, 10.1056/NEJMra064142 1996 Kilama, 2007, Towards an African-driven malaria vaccine development program: history and activities of the African malaria network trust, Am. J. Trop. Med. Hygiene, 77, 282, 10.4269/ajtmh.2007.77.282 Matlin, 2008, Focusing collaborative efforts on research and innovation for the health of the poor Mahmoud, 2006 Moran, 2009, Neglected diseases research and development: how much are we really spending?, Plos Med., 6, 10.1371/journal.pmed.1000030 Nyika, 2009, Composition, training needs and independence of ethics review committees across Africa: are the gate-keepers rising to the emerging challenges?, J. Med. Ethics, 35, 189, 10.1136/jme.2008.025189 Reich, 2000, The global drug gap, Science, 287, 1979, 10.1126/science.287.5460.1979 United Nations, 2005 World Health Organization, 2008